América Latina enfrenta otro año de contracción económica de acuerdo a los últimos pronósticos de la OCDE y la Cepal. Los economistas coinciden en que la región está condenada a un desempeño mediocre en tanto continúe dependiendo de las materias primas.
Mexico has the choice to remain as a low-value manufacturer of medicines, or develop as an innovator in its own right.
For Indonesia to join the ranks of high-income countries in the longer term it needs to start building a knowledge economy. Indonesia’s new patent law is a step in the wrong direction.
By turning back the clock on intellectual property, the U.N. would cut off developing countries from innovation.
Colombia’s compulsory license for a cancer medicine puts at risk its hard earned reputation as a safe country for foreign investment.
La transformación de la economía colombiana en los últimos años ha sido extraordinaria. Las políticas de apertura han contribuido a la atracción de inversión extranjera, la cual ha generado empleo y aumentado los ingresos de la población.
Canadian courts have turned patent utility requirements into a test of an inventor’s ability to predict the future.
Kenya’s small businesses are sitting on a rich pipeline of technology, brands and other knowledge assets that could thrive internationally if they are able to exploit their intellectual property.
Free Trade Agreements (FTAs) containing TRIPS-Plus intellectual property provisions have been widely criticised on the grounds they have the potential to raise medicine prices and undermine access to medicines, particularly in developing countries.